Y-Intercept (HK)’s Jazz Pharmaceuticals JAZZ Stock Holding History

Y-Intercept (HK)’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.48M	Buy	+10,301	New	+$2.26M	0.05%	586
2026 Q1	–	Sell	-6,242	Closed	-$1.06M	–	1807
2025 Q4	$1.06M	Buy	+6,242	New	+$957K	0.02%	955
2025 Q2	–	Sell	-9,721	Closed	-$1.21M	–	1832
2025 Q1	$1.21M	Buy	9,721 +7,090	+269%	+$925K	0.08%	340
2024 Q4	$324K	Sell	2,631 -10,068	-79%	-$1.19M	0.02%	911
2024 Q3	$1.41M	Sell	12,699 -11,622	-48%	-$1.27M	0.09%	305
2024 Q2	$2.6M	Buy	+24,321	New	+$2.67M	0.14%	180
2024 Q1	–	Sell	-3,377	Closed	-$415K	–	1570
2023 Q4	$415K	Buy	3,377 +1,372	+68%	+$171K	0.04%	681
2023 Q3	$260K	Sell	2,005 -4,069	-67%	-$542K	0.03%	822
2023 Q2	$753K	Buy	+6,074	New	+$817K	0.08%	395
2021 Q4	–	Sell	-5,058	Closed	-$659K	–	728
2021 Q3	$659K	Buy	5,058 +3,457	+216%	+$522K	0.12%	269
2021 Q2	$284K	Buy	+1,601	New	+$277K	0.07%	415
2021 Q1	–	Sell	-5,345	Closed	-$880K	–	700
2020 Q4	$880K	Buy	+5,345	New	+$796K	0.37%	55

Other funds holding JAZZ

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

ACM

Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Y-Intercept (HK)'s JAZZ Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 10,301 shares worth $2.48M. The stake represents 0.05% of the portfolio and ranks #586 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in JAZZ as recently as Q4 2025.

Y-Intercept (HK) first reported a position in JAZZ in Q4 2020 and has held it in 12 quarters since. The position peaked at $2.6M in Q2 2024. 164 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Y-Intercept (HK) held 10,301 shares of Jazz Pharmaceuticals worth $2.48M as of Q2 2026.
Jazz Pharmaceuticals was a new Y-Intercept (HK) position in Q2 2026.
Jazz Pharmaceuticals made up 0.05% of Y-Intercept (HK)'s portfolio in Q2 2026, its #586 holding.
Y-Intercept (HK) first reported a position in Jazz Pharmaceuticals in Q4 2020 and has held it in 12 quarters since.
Y-Intercept (HK)'s Jazz Pharmaceuticals position peaked at $2.6M in Q2 2024.
164 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.